Protein Sequencing Service segmentation by application reveals four primary demand drivers. Clinical diagnostics accounts for the largest share, roughly 35 % of total revenue, as hospitals and reference labs require high‑throughput sequencing to identify biomarkers, confirm disease‑associated variants, and support personalized medicine initiatives. Pharmaceutical development follows with an estimated 30 % contribution; biotech firms and large pharma outsource sequencing to accelerate target validation, lead optimization, and safety profiling during early‑stage drug discovery. Academic research, representing about 25 % of the market, sustains a steady flow of sequencing contracts for fundamental studies in proteomics, structural biology, and method development, often funded by government grants. Agricultural and biotech applications, though smaller at 10 %, are growing as crop‑improvement programs and livestock health monitoring increasingly depend on protein‑level insights. Collectively, these application segments shape the overall market size, with clinical and pharmaceutical uses driving the bulk of service volume while academic and agri‑biotech niches provide diversification and long‑term growth potential.